The Importance of Absolute Risk in Cardiovascular Medicine

We always talk about these relative risks and that's confusing for absolute risk. What kind of numbers are you even talking about when we talk about 50% reduction? Because that sounds... Yeah, well, let me give some examples. Other medicines to lower cholesterol on topostatens have been studied more recently. And the first set of those were not FDA approved until they showed not only that cholesterol and or other biomarkers were improved but they actually reduced hard cardiovascular endpoints.